ERBITUX

ImClone Systems Incorporated

Application Filed: 2007-02-01
Trademark Application Details
Trademark Logo ERBITUX

The mark comprises the word ERBITUX and an antibody design.

Mark For: ERBITUX® trademark registration is intended to cover the categories of pharmaceutical preparation, namely monoclonal antibody for the treatment of cancer. [all]

>Color is not claimed as a feature of the mark. The mark comprises the word ERBITUX and an antibody design.

Status

2022-04-22 UTC
DEAD REGISTRATION Cancelled Invalidated
The trademark application was registered, but subsequently it was cancelled or invalidated and removed from the registry.


Research OneLook Acronym Finder
Serial Number76672082
Registration Number3342502
Mark Literal ElementsERBITUX
Mark Drawing Type3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S)
Mark TypeTRADEMARK
Standard Character ClaimNo
RegisterPRINCIPAL
Current LocationPUBLICATION AND ISSUE SECTION 2007-11-27
Basis1(a)
Class StatusSECTION 8 - CANCEL
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseYes
Current UseYes
Intent To UseNo
Filed ITUNo
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Cancellation Code2
Attorney NameRobert E. Lee, Jr.
Law Office AssignedL40
Employee NameESTRADA, LINDA M

Timeline

2004-02-19Date of First Use
2004-02-19Date of Use In Commerce
2007-02-01Application Filed
2007-09-11Published
2007-09-11Published for Opposition
2007-11-27Location: PUBLICATION AND ISSUE SECTION
2007-11-27Trademark Registered
2014-07-04Cancelled
2014-07-04Status: Dead/Cancelled
2014-07-04Status: Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this
2018-07-08Transaction Date

Trademark Parties (Applicants & Owners)

Party: ImClone Systems Incorporated
Address450 East 29th Street New York, NEW YORK UNITED STATES 10016
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Design Search Codes

26.17.12Angles (geometric); Chevrons
261706Bands, diagonal; Bars, diagonal; Diagonal line(s), band(s) or bar(s); Lines, diagonal
261712Angles (geometric); Chevrons

Attorney of Record

Robert E. Lee, Jr.
Eli Lilly and Company
Lilly Corporate Center
Indianapolis IN 46285

Good, Services, and Codes

(CANCELLED)
IC 005. US 006 018 044 046 051 052. G & S: PHARMACEUTICAL PREPARATION, NAMELY MONOCLONAL ANTIBODY FOR THE TREATMENT OF CANCER. FIRST USE: 20040219. FIRST USE IN COMMERCE: 20040219

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
CC0000Color is not claimed as a feature of the mark.

Trademark Filing History

DescriptionDateProceeding Number
CANCELLED SEC. 8 (6-YR)2014-07-04
TEAS CHANGE OF OWNER ADDRESS RECEIVED2013-05-20
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2013-05-2088888
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2009-06-03
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2009-06-03
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY2009-02-04
TEAS CHANGE OF CORRESPONDENCE RECEIVED2008-03-21
REGISTERED-PRINCIPAL REGISTER2007-11-27
PUBLISHED FOR OPPOSITION2007-09-11
NOTICE OF PUBLICATION2007-08-22
LAW OFFICE PUBLICATION REVIEW COMPLETED2007-08-0878287
APPROVED FOR PUB - PRINCIPAL REGISTER2007-08-02
ASSIGNED TO LIE2007-07-1278287
AMENDMENT FROM APPLICANT ENTERED2007-07-1278287
PAPER RECEIVED2007-06-27
CORRESPONDENCE RECEIVED IN LAW OFFICE2007-06-2778287
NON-FINAL ACTION MAILED2007-04-16
NON-FINAL ACTION WRITTEN2007-04-1476795
ASSIGNED TO EXAMINER2007-04-1276795
APPLICATION FILING RECEIPT MAILED2007-02-13
NEW APPLICATION ENTERED IN TRAM2007-02-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed